Trial Profile
A multicentre, open-label study of propranolol in infants with proliferating infantile hemangioma requiring systemic therapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Nov 2018
Price :
$35
*
At a glance
- Drugs Propranolol (Primary)
- Indications Haemangioma
- Focus Adverse reactions
- Sponsors Pierre Fabre
- 07 Nov 2018 Status changed to completed.
- 05 Oct 2017 New trial record